RxDoctor Payments Data

Philip Larsen, DPM

Foot & Ankle Surgery · Henderson, NVNPI 1245222181

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 181 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 14.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $874 and has fallen 61.7% since, to $335 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in NV, where the typical reported total is $3,921.

$3,921in general payments, 2019–2025

Across 181 payments — averaging $21.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Treace Medical Concepts, Inc.$557
  • Paratek Pharmaceuticals, Inc.$392
  • Amgen$350
  • Organogenesis Inc.$323
  • Stryker$280
  • Nevro Corp.$239
  • plus $2K from 31 others

What the payments were for

  • Food & beverage$3,921100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,921 in reported general payments places this provider in the 50th percentile of 84 foot & ankle surgery providers in Nevada.

See all foot & ankle surgery providers in Nevada

Medicare billing

Part B allowed, 2024
$247,688
Medicare patients
461
Services billed
10,050

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin17$264
Meloxicam74$75
Terbinafine Hcl13$43

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Henderson

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →